NIVF
Income statement / Annual
Last year (2025), NewGenIvf Group Ltd's total revenue was $4.73 M,
a decrease of 13.01% from the previous year.
In 2025, NewGenIvf Group Ltd's net income was $9.88 M.
See NewGenIvf Group Ltd,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$4.73 M |
$5.43 M |
$5.14 M |
$5.94 M |
$4.12 M |
| Cost of Revenue |
$3.77 M
|
$3.61 M
|
$3.45 M
|
$4.41 M
|
$3.09 M
|
| Gross Profit |
$955.85 K
|
$1.83 M
|
$1.68 M
|
$1.54 M
|
$1.03 M
|
| Gross Profit Ratio |
0.2
|
0.34
|
0.33
|
0.26
|
0.25
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$10.49 M
|
$2.78 M
|
$1.62 M
|
$1.10 M
|
$801.33 K
|
| Selling & Marketing Expenses |
$1.19 M
|
$206.31 K
|
$18.03 K
|
$36.19 K
|
$24.69 K
|
| Selling, General & Administrative Expenses |
$11.68 M
|
$2.99 M
|
$1.64 M
|
$1.14 M
|
$826.02 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$64.00
|
$0.00
|
| Operating Expenses |
$11.68 M
|
$2.99 M
|
$1.64 M
|
$1.14 M
|
$826.02 K
|
| Cost And Expenses |
$15.45 M
|
$6.59 M
|
$5.09 M
|
$5.55 M
|
$3.92 M
|
| Interest Income |
$2.25 K
|
$6.95 K
|
$518.00
|
$21.00
|
$63.00
|
| Interest Expense |
$616.42 K
|
$778.66 K
|
$46.18 K
|
$77.76 K
|
$88.29 K
|
| Depreciation & Amortization |
$499.50 K
|
$206.26 K
|
$229.71 K
|
$303.94 K
|
$342.54 K
|
| EBITDA |
$10.84 M |
$24.26 K |
$384.31 K |
$725.69 K |
$587.01 K |
| EBITDA Ratio |
2.29
|
0
|
0.07
|
0.12
|
0.14
|
| Operating Income Ratio |
-2.27
|
-0.21
|
0.01
|
-0.08
|
0.05
|
| Total Other Income/Expenses Net |
$20.46 M
|
$199.69 K
|
$66.18 K
|
$1.01 M
|
-$42.57 K
|
| Income Before Tax |
$9.73 M
|
-$961.00 K
|
$108.42 K
|
$500.65 K
|
$156.18 K
|
| Income Before Tax Ratio |
2.06
|
-0.18
|
0.02
|
0.08
|
0.04
|
| Income Tax Expense |
$0.00
|
-$487.00 K
|
$0.00
|
$208.14 K
|
$294.72 K
|
| Net Income |
$9.88 M
|
-$525.00 K
|
$130.19 K
|
$458.67 K
|
-$533.00
|
| Net Income Ratio |
2.09
|
-0.1
|
0.03
|
0.08
|
-0
|
| EPS |
16.8 |
-22.306257175 |
12.435375475 |
62.5155841 |
-0.0048386675 |
| EPS Diluted |
16.8 |
-22.306257175 |
12.435375475 |
62.5155841 |
-0.0048386675 |
| Weighted Average Shares Out |
$588.24 K
|
$588.24 K
|
$262.19 K
|
$262.19 K
|
$262.19 K
|
| Weighted Average Shares Out Diluted |
$588.24 K
|
$588.24 K
|
$262.19 K
|
$262.19 K
|
$262.19 K
|
| Link |
|
|
|
|
|
